Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-41443532 in Type 2 Diabetes Mellitus
NCT01230749Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of JNJ-41443532 in type 2 diabetes mellitus (T2DM), sponsored by Johnson & Johnson. Started Dec 2010; status: completed.
02
Drugs
JNJ-41443532
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01230749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230749.